FOIA Requests & Responses

Follow-Up — November 19, 2026

During a comprehensive review of historical FDA adverse event datasets, we recovered the original July 14, 2025, release containing AER 2025-US-008923.

Our preliminary comparison indicates that this record is absent from the November 2026 dataset.

We have retained the original FDA file and are conducting an independent comparison of historical and current records. We have not received a definitive explanation establishing what the 266 deaths represented or why the record is no longer appearing in our preliminary reconstruction.

New York FOIL Request: Buoy’s Law Enforcement
October 28, 2026

Latest FDA Response 9.25.25

Overview

Escalating Adverse Event Reports


These documents were obtained via FOIA request 2025-3031 and represent the FDA’s internal safety reviews through March 2024. Current adverse event totals may be significantly higher.


Is Zorbium® Missing Batch-Level Safety Data?







August 26, 2025

FDA Response 8.26.25

Subject: Veterinary Distribution of Zorbium®
Date: May 24, 2024
Source: New York State Department of Health

Subject: Safety Review Threshold Inquiry to FDA
Date: January 2, 2025
Source: FDA.HHS.Gov

Subject: Sales data for Zorbium, manufactured by Elanco, specifically, information on the total
number of Zorbium boxes sold since January 2022
Date: September 17, 2024
Source: US Dept. of Justice

© 2025 Zorbium.com Research FDA May be shared for educational/research purposes with attribution

Subject: Subject: FOIA Request – Safety Thresholds and Public Notification Criteria for Veterinary Drugs
Date: March 30, 2025
Source: FDA-CVM

© 2025 Zorbium.com Research FDA May be shared for educational/research purposes with attribution